These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 30803176

  • 21. The in vitro anti-fibrotic effect of Pirfenidone on human pterygium fibroblasts is associated with down-regulation of autocrine TGF-β and MMP-1.
    Tao Y, Chen Q, Zhao C, Yang X, Cun Q, Yang W, Zhang Y, Zhu Y, Zhong H.
    Int J Med Sci; 2020; 17(6):734-744. PubMed ID: 32218695
    [Abstract] [Full Text] [Related]

  • 22. Oral pirfenidone protects against fibrosis by inhibiting fibroblast proliferation and TGF-β signaling in a murine colitis model.
    Li G, Ren J, Hu Q, Deng Y, Chen G, Guo K, Li R, Li Y, Wu L, Wang G, Gu G, Li J.
    Biochem Pharmacol; 2016 Oct 01; 117():57-67. PubMed ID: 27498142
    [Abstract] [Full Text] [Related]

  • 23. Effect of pirfenidone on proliferation, TGF-β-induced myofibroblast differentiation and fibrogenic activity of primary human lung fibroblasts.
    Conte E, Gili E, Fagone E, Fruciano M, Iemmolo M, Vancheri C.
    Eur J Pharm Sci; 2014 Jul 16; 58():13-9. PubMed ID: 24613900
    [Abstract] [Full Text] [Related]

  • 24. MicroRNA-29 mediates TGFβ1-induced extracellular matrix synthesis by targeting wnt/β-catenin pathway in human orbital fibroblasts.
    Tan J, Tong BD, Wu YJ, Xiong W.
    Int J Clin Exp Pathol; 2014 Jul 16; 7(11):7571-7. PubMed ID: 25550793
    [Abstract] [Full Text] [Related]

  • 25. [Effects of silencing Smad ubiquitination regulatory factor 2 on the function of human hypertrophic scar-derived fibroblasts].
    Zhang Z, Kuang F, Liu CL, Chen B, Tang WB, Li XJ.
    Zhonghua Shao Shang Za Zhi; 2017 Mar 20; 33(3):145-151. PubMed ID: 28316163
    [Abstract] [Full Text] [Related]

  • 26. Disulfiram Exerts Antiadipogenic, Anti-Inflammatory, and Antifibrotic Therapeutic Effects in an In Vitro Model of Graves' Orbitopathy.
    Wang X, Yang S, Ye H, Chen J, Shi L, Feng L, Wang X, Zhang T, Chen R, Xiao W, Yang H.
    Thyroid; 2022 Mar 20; 32(3):294-305. PubMed ID: 34605662
    [Abstract] [Full Text] [Related]

  • 27. Novel Roles of Chloroquine and Hydroxychloroquine in Graves' Orbitopathy Therapy by Targeting Orbital Fibroblasts.
    Guo Y, Li H, Chen X, Yang H, Guan H, He X, Chen Y, Pokharel S, Xiao H, Li Y.
    J Clin Endocrinol Metab; 2020 Jun 01; 105(6):1906-17. PubMed ID: 32249902
    [Abstract] [Full Text] [Related]

  • 28. Lutein targeting orbital fibroblasts attenuates fibrotic and inflammatory effects in thyroid-associated ophthalmopathy.
    Hei X, Lin B, Wu P, Li X, Mao Z, Huang S, Zhang F, Zhou M, Ke Y, Yang H, Huang D.
    Exp Eye Res; 2023 Jul 01; 232():109515. PubMed ID: 37207866
    [Abstract] [Full Text] [Related]

  • 29. Pirfenidone inhibits carbon tetrachloride- and albumin complex-induced liver fibrosis in rodents by preventing activation of hepatic stellate cells.
    Zhao XY, Zeng X, Li XM, Wang TL, Wang BE.
    Clin Exp Pharmacol Physiol; 2009 Oct 01; 36(10):963-8. PubMed ID: 19413596
    [Abstract] [Full Text] [Related]

  • 30. Antifibrotic effects of quercetin in primary orbital fibroblasts and orbital fat tissue cultures of Graves' orbitopathy.
    Yoon JS, Chae MK, Jang SY, Lee SY, Lee EJ.
    Invest Ophthalmol Vis Sci; 2012 Aug 31; 53(9):5921-9. PubMed ID: 22871832
    [Abstract] [Full Text] [Related]

  • 31. [Interaction between P311 and transforming growth factor beta 1 and its effect on the function of murine fibroblasts].
    Zhang L, Li H, Yao Z, Yang S, He W, Wu J, Luo G.
    Zhonghua Shao Shang Za Zhi; 2016 Apr 31; 32(4):208-15. PubMed ID: 27093932
    [Abstract] [Full Text] [Related]

  • 32. PH20 Inhibits TGFβ1-Induced Differentiation of Perimysial Orbital Fibroblasts via Hyaluronan-CD44 Pathway in Thyroid-Associated Ophthalmopathy.
    Ma R, Ren H, Xu B, Cheng Y, Gan L, Zhang R, Wu J, Qian J.
    Invest Ophthalmol Vis Sci; 2019 Apr 01; 60(5):1431-1441. PubMed ID: 30947333
    [Abstract] [Full Text] [Related]

  • 33. The Antiangiogenesis Effect of Pirfenidone in Wound Healing In Vitro.
    Liu X, Yang Y, Guo X, Liu L, Wu K, Yu M.
    J Ocul Pharmacol Ther; 2017 Nov 01; 33(9):693-703. PubMed ID: 28933986
    [Abstract] [Full Text] [Related]

  • 34. The Potential Role of Osteopontin in the Pathogenesis of Graves' Ophthalmopathy.
    Lou H, Wu LQ, Wang H, Wei RL, Cheng JW.
    Invest Ophthalmol Vis Sci; 2021 Sep 02; 62(12):18. PubMed ID: 34546326
    [Abstract] [Full Text] [Related]

  • 35. Potential treatment for vocal fold scar with pirfenidone.
    Kodama H, Kumai Y, Nishimoto K, Toya Y, Miyamaru S, Furushima S, Yumoto E.
    Laryngoscope; 2018 May 02; 128(5):E171-E177. PubMed ID: 29171670
    [Abstract] [Full Text] [Related]

  • 36. [Pirfenidone inhibits proliferation of rabbit tenon fibroblasts by down-regulating TGF-β3 in the TGF-β/Smad pathway].
    Chen X, Shen Y, Zhao H, Guo W.
    Nan Fang Yi Ke Da Xue Xue Bao; 2021 Nov 20; 41(11):1692-1699. PubMed ID: 34916196
    [Abstract] [Full Text] [Related]

  • 37. Pirfenidone inhibits proliferation, arrests the cell cycle, and downregulates heat shock protein-47 and collagen type I in rat hepatic stellate cells in vitro.
    Xiang XH, Jiang TP, Zhang S, Song J, Li X, Yang JY, Zhou S.
    Mol Med Rep; 2015 Jul 20; 12(1):309-14. PubMed ID: 25738437
    [Abstract] [Full Text] [Related]

  • 38. Down-regulation of miR-21-5p by pirfenidone to inhibit fibroblast proliferation in the treatment of acquired tracheal stenosis.
    Li W, Huang P, Wei J, Tan S, Liu G, Yang Q, Wang G.
    Clin Respir J; 2024 Jan 20; 18(1):e13727. PubMed ID: 38151323
    [Abstract] [Full Text] [Related]

  • 39. Potential Therapeutic Activity of Berberine in Thyroid-Associated Ophthalmopathy: Inhibitory Effects on Tissue Remodeling in Orbital Fibroblasts.
    Diao J, Chen X, Mou P, Ma X, Wei R.
    Invest Ophthalmol Vis Sci; 2022 Sep 01; 63(10):6. PubMed ID: 36094643
    [Abstract] [Full Text] [Related]

  • 40. Transforming growth factor-β1 suppress pentraxin-3 in human orbital fibroblasts.
    Diao J, Chen X, Jiang L, Mou P, Wei R.
    Endocrine; 2020 Oct 01; 70(1):78-84. PubMed ID: 32300954
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.